|
Click
on the title for abstract and CV
|
|
Programme
Friday, 31st January |
|
Session
1: Androgens and Men's Health I
Chairman: Dr. Michael Hansen
|
|
The Effect of Androgens
on the Vascular System
Prof. Jesper Mehlsen, Medical Director, Dept.
of Clinical Physiology & Nuclear Medicine, Frederiksberg
Hospital, University of Copenhagen, Denmark. |
|
Diabetes and Testosterone
Dr. T.R.Trinick, Consultant Chemical Pathologist
and Physician, Ulster Community and Hospitals Trust,
The Ulster Hospital, Belfast, UK |
|
|
|
Session
2: Androgens and Men's Health II
Chairman: Prof. Jesper.Mehlsen
|
|
Androgens and bones.
Prof. Richard Eastell Division of Clinical
Sciences, Bone Metabolism Group, Northern General
Hospital, Sheffield, UK. |
|
Androgen deficiency in
the adult and its relevance to primary care.
Prof. Louis Gooren Dept. of Endocrinology,
VUMC, The Netherlands. |
|
back
to top
|
Session
3: Androgens and the Brain
Chairman: Dr Peter Mellett |
|
Serum Testosterone
in men with Alzheimer's Disease.
Dr. Eva Hogervorst OPTIMA, University of Oxford,
Radcliffe Infirmary, Oxford, UK. |
|
Androgens and
Brain Function.
Prof. Suzana Petanceska, Assistant Professor
of Psychiatry and cell biology at NYU School of Medicine
and the Nathan Kline Institute. |
|
back
to top
|
|
Session
4: Androgen Replacement
Chairman: Dr Joel Kaufman
|
|
Current recommendations
on use of androgens in the andropause.
Prof. Bruno Lunenfeld Faculty of Life Sciences,
Bar-Ilan University, Ramat Gan, Israel |
|
Towards the Perfect Androgen;
a customised approach to treatment options.
Dr. Bruce Biundo, Professional Compounding
Centers of America, Houston, Texas, USA |
|
back
to top
|
Programme Saturday 1st February |
|
Session
5:The Prostate I
Chairman: Prof. Aksam Yassin
|
|
Androgens, the prostate,
and the impact of neoplasia
Mr Mark Feneley, Institute of Urology,
London UK |
|
Androgen Replacement
and Prostate Disease, Benign and Malignant
Dr Joel Kaufman, Aurora Urology, P.C., Aurora,
Colorado, USA |
|
back
to top
|
|
Session
6:The Prostate II
Chairman: Mr Mark Feneley
|
|
BPH and Sexuality: Etiology,
Pathogenesis & Therapy Consequences.
Prof. Aksam Yassin, Dept. of Urology &
Human Sexuality, Buckhoerner Moor 110, Norderstedt,
Germany. |
|
back
to top
|
| Session
6a - Androgens and the
Brain II |
|
Cognitive
Decline in the Andropause; Exploring the androgen
connection
Dr Robert
Tan, Associate Professor,
University of Texas-Houston |
|
Alzheimer's
Disease; molecular risk factors and therapeutic approaches
Dr Ralph
Martins, Sir James McCusker
Alzheimer's Disease Research Unit, Department
of Psychiatry, University of Western Australia. |
|
|
Cholesterol Metabolism : A Therapeutic
Target for Alzheimer's Disease
Dr Larry Refolo, Scientific
Director, The Institute of the Study of the Aging,
New York, USA |
|
back
to top
|
|